Boothbay Fund Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1323 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1373 |
|
|
2022
Q2 | – | Sell |
-246,300
| Closed | -$177K | – | 1943 |
|
|
2022
Q1 | $177K | Buy |
246,300
+230,477
| +1,457% | +$166K | ﹤0.01% | 1546 |
|
|
2021
Q4 | $36K | Sell |
15,823
-59,417
| -79% | -$135K | ﹤0.01% | 1623 |
|
|
2021
Q3 | $217K | Buy |
75,240
+24,468
| +48% | +$70.6K | 0.01% | 1285 |
|
|
2021
Q2 | $192K | Buy |
50,772
+16,470
| +48% | +$62.3K | 0.01% | 1371 |
|
|
2021
Q1 | $116K | Buy |
34,302
+14,970
| +77% | +$50.6K | ﹤0.01% | 1224 |
|
|
2020
Q4 | $54K | Sell |
19,332
-1,288
| -6% | -$3.6K | ﹤0.01% | 1028 |
|
|
2020
Q3 | $52K | Buy |
+20,620
| New | +$52K | ﹤0.01% | 873 |
|
|
2019
Q4 | – | Sell |
-71,000
| Closed | -$278K | – | 732 |
|
|
2019
Q3 | $278K | Buy |
+71,000
| New | +$278K | 0.03% | 500 |
|
|
2019
Q2 | – | Sell |
-104,000
| Closed | -$852K | – | 620 |
|
|
2019
Q1 | $852K | Buy |
104,000
+38,148
| +58% | +$313K | 0.08% | 199 |
|
|
2018
Q4 | $364K | Buy |
+65,852
| New | +$364K | 0.05% | 274 |
|